Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Thiol-Disulfide Homeostasis and Ischemia-Modified Albumin Levels on In Vitro Fertilization Outcomes in Couples With Male Factor Infertility

NCT07033429 is registered in ClinicalTrials.gov with Duzce University as lead sponsor.

NCT NCT07033429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07033429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Thiol-Disulfide Homeostasis and Ischemia-Modified Albumin Levels on In Vitro Fertilization Outcomes in Couples With Male Factor Infertility
Lead sponsor
Duzce University
Phase
Observational
Overall status
Completed
Start date
April 1, 2023
Completion date
June 1, 2025
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nt/tt ratio, serum disulfide/tt ratio, serum ischemia-modified albumin (ima), the serum native thiol (nt), total thiol (tt)